Feed / CAI

Caris Life Sciences, Inc.

CAI

Healthcare · 28.00 +7.2% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Caris Life Sciences, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 29 directly disclosed connections are confirming.

Company+7.2% todayVolume comparison unavailable
Market group0 of 10 activeGrowth-Oriented Stocks · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Caris said higher clinical case volume, reimbursement, and average selling prices from enhanced contracting drove revenue growth.

Invalidation: The isolated read changes if CAI's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind CAI

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ILMNIllumina, Inc.supplierMar 3, 2026

Other companies offering testing in the precision oncology industry include Illumina, NeoGenomics, Myriad Genetics, Laboratory Corporation of America, Quest Diagnostics, and BostonGene.

ABBVAbbVie Inc.partnerMay 8, 2026

Our molecular profiling solutions and the data generated by our multi-omic technology platform also provide value to our biopharma partners, such as Moderna, AbbVie, Xencor, Merck KGaA and Genentech, through partnerships that aim to increase the probability o…

Depended on by

BLLNBillionToOne, Inc.competitorMar 11, 2026

In the oncology market, our main competitors for our therapy selection and response monitoring tests include Caris Life Sciences, Inc., Foundation Medicine, Inc., which was acquired by Roche Holdings, Inc., Guardant Health, Inc., NeoGenomics Laboratories, Inc…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 30 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CAI is currently a Early Follower in the organic co-movement group Growth-Oriented Stocks. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for CAI; it is not active in the latest market snapshot.